Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot study and promising future directions.

Tu J, Foster RS, Bint LJ, Halbert AR.

Australas J Dermatol. 2014 Feb;55(1):63-9. doi: 10.1111/ajd.12125. Epub 2013 Dec 22.

PMID:
24359523
2.

Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.

Balestri R, Neri I, Patrizi A, Angileri L, Ricci L, Magnano M.

J Eur Acad Dermatol Venereol. 2015 Jan;29(1):14-20. doi: 10.1111/jdv.12665. Epub 2014 Aug 29. Review.

PMID:
25174683
3.

Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients.

Foster RS, Bint LJ, Halbert AR.

Australas J Dermatol. 2012 Feb;53(1):52-6. doi: 10.1111/j.1440-0960.2011.00837.x. Epub 2011 Dec 29.

PMID:
22309333
4.

A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.

Wheless JW, Almoazen H.

J Child Neurol. 2013 Jul;28(7):933-6. doi: 10.1177/0883073813488664. Epub 2013 May 16.

PMID:
23680945
5.

First left-right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex.

Tanaka M, Wataya-Kaneda M, Nakamura A, Matsumoto S, Katayama I.

Br J Dermatol. 2013 Dec;169(6):1314-8. doi: 10.1111/bjd.12567.

PMID:
23909960
6.

Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1) ) in two patients with tuberous sclerosis.

Mutizwa MM, Berk DR, Anadkat MJ.

Br J Dermatol. 2011 Oct;165(4):922-3. doi: 10.1111/j.1365-2133.2011.10476.x. No abstract available.

PMID:
21692776
7.

Topical everolimus for facial angiofibromas in the tuberous sclerosis complex. A first case report.

Dill PE, De Bernardis G, Weber P, Lösch U.

Pediatr Neurol. 2014 Jul;51(1):109-13. doi: 10.1016/j.pediatrneurol.2014.02.016. Epub 2014 Mar 1.

PMID:
24810875
8.

A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.

Wataya-Kaneda M, Tanaka M, Nakamura A, Matsumoto S, Katayama I.

Br J Dermatol. 2011 Oct;165(4):912-6. doi: 10.1111/j.1365-2133.2011.10471.x.

PMID:
21692771
9.

Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial.

Wataya-Kaneda M, Nakamura A, Tanaka M, Hayashi M, Matsumoto S, Yamamoto K, Katayama I.

JAMA Dermatol. 2017 Jan 1;153(1):39-48. doi: 10.1001/jamadermatol.2016.3545.

PMID:
27837201
10.

Topical 0.2% rapamycin to treat facial angiofibromas and hypomelanotic macules in tuberous sclerosis.

Knöpfel N, Martín-Santiago A, Bauza A, Hervás JA.

Actas Dermosifiliogr. 2014 Oct;105(8):802-3. doi: 10.1016/j.ad.2013.09.013. Epub 2013 Dec 17. English, Spanish. No abstract available.

PMID:
24355193
11.

Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.

Haemel AK, O'Brian AL, Teng JM.

Arch Dermatol. 2010 Jul;146(7):715-8. doi: 10.1001/archdermatol.2010.125. No abstract available.

PMID:
20644030
12.

Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin.

Koenig MK, Hebert AA, Roberson J, Samuels J, Slopis J, Woerner A, Northrup H.

Drugs R D. 2012 Sep 1;12(3):121-6. doi: 10.2165/11634580-000000000-00000.

13.

Treatment of angiofibromas in tuberous sclerosis complex: the effect of topical rapamycin and concomitant laser therapy.

Park J, Yun SK, Cho YS, Song KH, Kim HU.

Dermatology. 2014;228(1):37-41. doi: 10.1159/000357033. Epub 2013 Dec 21.

PMID:
24401865
14.

Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis.

Cinar SL, Kartal D, Bayram AK, Canpolat M, Borlu M, Ferahbas A, Per H.

Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):27-32. doi: 10.4103/0378-6323.190844.

15.

[Facial angiofibromas associated to tuberous sclerosis treated with topical sirolimus].

Tiedemann Svendsen M, Bygum A, Hansen LK, Broesby-Olsen S.

Ugeskr Laeger. 2013 Oct 21;175(43):2569-70. Danish.

PMID:
24629155
16.

Targeted topical and combination laser surgery for the treatment of angiofibromas.

Bae-Harboe YS, Geronemus RG.

Lasers Surg Med. 2013 Nov;45(9):555-7. doi: 10.1002/lsm.22189.

PMID:
24136238
17.

Formulation and characterization of a 0.1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas.

Bouguéon G, Lagarce F, Martin L, Pailhoriès H, Bastiat G, Vrignaud S.

Int J Pharm. 2016 Jul 25;509(1-2):279-84. doi: 10.1016/j.ijpharm.2016.05.064. Epub 2016 Jun 1.

PMID:
27260135
18.

Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol.

DeKlotz CM, Ogram AE, Singh S, Dronavalli S, MacGregor JL.

Arch Dermatol. 2011 Sep;147(9):1116-7. doi: 10.1001/archdermatol.2011.254. No abstract available.

PMID:
21931059
19.

Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma.

Salido R, Garnacho-Saucedo G, Cuevas-Asencio I, Ruano J, Galán-Gutierrez M, Vélez A, Moreno-Giménez JC.

J Eur Acad Dermatol Venereol. 2012 Oct;26(10):1315-8. doi: 10.1111/j.1468-3083.2011.04212.x. Epub 2011 Aug 11.

PMID:
21834948
20.

Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin.

Kaufman McNamara E, Curtis AR, Fleischer AB Jr.

J Dermatolog Treat. 2012 Feb;23(1):46-8. doi: 10.3109/09546634.2010.489598. Epub 2010 Aug 1.

PMID:
20673154

Supplemental Content

Support Center